Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Profound Medical Corp. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 44 | 3 | 52 | +11 |
| Shares | 9.42M | 815.5K | 13.8M | +5.17M (+60.1%) |
| Value | $75.0M | $6.49M | $103.1M | +$34.6M (+50.5%) |
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Profound Medical Corp. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 875,709 | $6.58M | 0.00% |
| Magnetar Financial LLC | 509,400 | $3.83M | 0.09% |
| MMCAP International Inc. SPC | 490,000 | $3.68M | 0.55% |
| Altium Capital Management LP | 485,000 | $3.64M | 1.13% |
| Ring Mountain Capital, LLC | 277,859 | $2.09M | 1.40% |
| Picton Mahoney Asset Management | 250,000 | $1.88M | 0.07% |
| Formula Growth Ltd | 250,000 | $1.88M | 0.64% |
| Stonepine Capital Management, LLC | 200,000 | $1.50M | 1.21% |
| Alyeska Investment Group, L.P. | 160,000 | $1.20M | 0.00% |
| Anson Funds Management LP | 110,000 | $826.1K | 0.10% |
| Vestcor Inc | 50,000 | $376.0K | 0.01% |
| Truist Financial Corp | 50,000 | $375.5K | 0.00% |
| Maven Securities LTD | 50,000 | $375.5K | 0.06% |
| AYAL Capital Advisors Ltd | 50,000 | $375.5K | 0.19% |
| XTX Topco Ltd | 15,132 | $113.6K | 0.01% |
| Signaturefd, LLC | 616 | $4.63K | 0.00% |
| Tower Research Capital LLC (TRC) | 316 | $2.37K | 0.00% |
Sold out (6)
Institutions that held Profound Medical Corp. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Millennium Management LLC | 53,633 | $426.9K |
| Silvercrest Asset Management Group LLC | 15,001 | $119.4K |
| Cetera Investment Advisers | 11,619 | $92.5K |
| Golden State Equity Partners | 3,961 | $31.5K |
| Group One Trading, L.P. | 1 | $8 |
| Simplex Trading, LLC | 83 | $0 |
Not filed for Q4 2024 yet (3)
Institutions that held Profound Medical Corp. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 760,457 | $6.05M |
| Raymond James & Associates | 43,005 | $342.3K |
| Raymond James Trust N.A. | 12,000 | $95.5K |